Form D · Biotechnology
Seeing Medicines, Inc.
Arden, NC · CIK 0001869755
Offering snapshot reported Jun 28, 2021 · SEC filing
- Reported sold
- $6.91M Offering amount: $8.41M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2021 | Initial | $6,913,542 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-404441
Source: Form D, filed Jun 28, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Casey Cunningham | Director |
| Hermanus L. Jooste | Director, Executive |
| Omar Khalil | Director |
| Edmund Mickunas | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
42 Hidden Hills Way
Arden, NC, 28704
Arden, NC, 28704